Rapidus 50 mg 20 tablets

Rapidus 50 mg 20 tablets

Composition:
Each film-coated tablet contains:
Diclofenac potassium – 50 mg.
Description:
Diclofenac potassium is a nonsteroidal anti-inflammatory drug (NSAID) with pronounced antirheumatic, analgesic, anti-inflammatory, and antipyretic properties.
Indications:
Rheumatoid arthritis
Osteoarthritis
Low back pain
Migraine attacks
Acute musculoskeletal disorders and injuries
Sprains, strains, and dislocations
Pain relief in fractures
Acute gout
Pain and inflammation associated with orthopedic and dental procedures
Dosage and Administration:
For oral use. Tablets should be swallowed whole with liquid after meals.
The lowest effective dose should be used to control symptoms.
Recommended daily dose: 100–150 mg divided into 2 or 3 doses.
In milder cases: 75–100 mg per day in 2 or 3 divided doses.
Primary dysmenorrhea:
Typical daily dose: 50–150 mg.
Initial dose of 50 mg is usually sufficient.
If needed, a starting dose of 100 mg may be used. The maximum dose of 200 mg/day can be reached over several menstrual cycles.
Treatment should begin at the onset of symptoms and continue for a few days.
Migraine attacks:
Initial dose: 50 mg at the first signs of an attack.
If no relief is obtained within 2 hours, an additional 50 mg may be taken.
Further 50 mg doses may be taken at 4–6 hour intervals as needed, not exceeding a total of 200 mg/day.
Adolescents aged 14 and older:
Daily dose of 75–100 mg divided into 2–3 doses is usually sufficient.
The maximum daily dose should not exceed 150 mg.
Contraindications:
Children under 14 years of age
Hypersensitivity to diclofenac, aspirin, or any component of the formulation
Severe cardiac, hepatic, or renal insufficiency
Bradycardia, severe hypotension
Gastrointestinal bleeding
Pregnancy and breastfeeding.
Precautions:
Discontinue use if liver dysfunction develops.
Patients with cardiovascular disease should be monitored during therapy.
Frail, elderly, or underweight patients should be given the minimum effective therapeutic dose.
Before initiating therapy, patients should undergo clinical evaluation in cases of:
Peptic ulcers
History of intestinal bleeding
Hepatic or renal impairment (including history)
Hypertension
In patients with bronchial asthma, hay fever, acute or chronic respiratory diseases, or nasal polyps, administration may provoke bronchospasm or asthma attacks. Treatment of such conditions is symptomatic.
Adverse Reactions:
Headache, dizziness, vertigo
Tachycardia/bradycardia, hypertension, arrhythmias, heart failure
Abdominal pain, vomiting, cramps, flatulence, nausea, diarrhea, dyspepsia
Fluid retention, edema
Rash, angioedema.
Storage:
Store at temperatures not exceeding 30°C, in a dry place out of the reach of children.
Packaging:
The carton contains 2 blister packs of 10 film-coated tablets each, along with a paper package insert.